Testimony in Favor of HB 613 to Permit Licensed Pharmacists to Prescribe and Dispense Contraceptives

Friday Feb 24th, 2017

Following is testimony given by Rebecca Dineen, Deputy Commissioner of Maternal and Child Health. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on February 10, 2017.

Thank you Chairwoman Pendergrass and members of the Health and Government Operations Committee calling this hearing and inviting the Baltimore City Health Department to comment on this bill today.

I am testifying on behalf of Dr. Leana Wen, Baltimore City Health Commissioner, in support of House Bill 613. By expanding access to contraceptive medications and devices, House Bill 613 will decrease the number of unintended pregnancies and improve pregnancy outcomes.

In 2016, there were 669 teen births in Baltimore City, the most among all Maryland jurisdictions. Baltimore City has the highest percentage of low birth weights at 12.3 percent and is tied for first in its share of very low birth weights at 2.6 percent. 

According to a nationally representative survey of adult women published in 2016 in the Journal of Women’s Health, between a quarter and a third of women reported issues obtaining a prescription or refills for oral contraception. Women in the study cited challenges such as visiting clinics, clinicians requiring a clinic visit, and not having a regular doctor or clinic as obstacles to obtaining contraceptives. These difficulties would be mitigated by House Bill 613.

This bill will help address the long-term physical, psychological, social, and economic consequences of unintended pregnancies by expanding access to vital, FDA-approved contraceptive medications and devices.

As a result, the Baltimore City Health Department respectfully requests a favorable report on House Bill 613.

 

Related Stories

Letter in Support for Teen Pregnancy Prevention Funding

TO:                Senator Chris Van Hollen
FROM:          Dr. Leana Wen, Baltimore City Health Commissioner
RE:                Support for Adolescent Health Education

Dear Senator Van Hollen:

On July 6, 2017, the Baltimore City Health Department (BCHD) received notice from the Department of Health and Human Services’ Office of Adolescent Health (OAH) that the grant period for the U Choose evidence-based program would be shortened by two years, which will reduce the overall funding for this program by $3.5M over two years. This change will result in reduced access to evidence-based teen pregnancy curricula for thousands of students in Baltimore, creating a vacuum of critical health education for thousands of vulnerable teens.

Testimony in favor of SB 868 Prescribing and Dispensing Naloxone to Non-certificate Holders

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 16, 2017.

Testimony in favor for HB 909 Maryland Health Insurance Coverage Protection Act

Following is testimony given by Legislative Director Jeff Amoros. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 10, 2017.